RICHTER SYNDROME

Clinical trials for RICHTER SYNDROME explained in plain language.

Never miss a new study

Get alerted when new RICHTER SYNDROME trials appear

Sign up with your email to follow new studies for RICHTER SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 8 Completed 1

Immunotherapy combo shows promise for Tough-to-Treat blood cancers

Disease control Completed

This phase 2 trial tested the immunotherapy drug pembrolizumab (Keytruda) alone or combined with idelalisib or ibrutinib in 65 patients with chronic lymphocytic leukemia (CLL) or low-grade B-cell non-Hodgkin lymphoma (NHL) that had returned or stopped responding to treatment. The…

Matched conditions: RICHTER SYNDROME

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC

RICHTER SYNDROME

Get alerted when new RICHTER SYNDROME trials appear

Immunotherapy combo shows promise for Tough-to-Treat blood cancers